SCHEMBL5990880

SCHEMBL5990880

CCCc1nc(C)c(C(N)=O)[nH]1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.39
GLA P06280 1/20 0.36
POLB P06746 2/20 0.34
ALDH1A1 P00352 2/20 0.33
HSD17B10 Q99714 1/20 0.33
USP2 O75604 1/20 0.33
TSHR P16473 1/20 0.33
KDM4E B2RXH2 2/20 0.33
CYP1A2 P05177 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
RECQL P46063 1/20 0.33
IKBKB O14920 1/20 0.32
GPR84 Q9NQS5 5/20 0.32
PDPK1 O15530 1/20 0.32
KMT2A Q03164 1/20 0.31
BACE1 P56817 1/20 0.31
XDH P47989 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11000182 0.84 GLA (0.37) MAPK1GLAPOLBALDH1A1HSD17B10
SCHEMBL7234563 0.82 ALDH1A1 (0.39) MAPK1GLAPOLBALDH1A1HSD17B10
SCHEMBL30296121 0.82 POLB (0.38) MAPK1GLAPOLBALDH1A1HSD17B10
SCHEMBL11050960 0.82 GLA (0.36) MAPK1GLAPOLBALDH1A1KDM4E
SCHEMBL11051550 0.81 MAPK1 (0.35) MAPK1GLAPOLBTSHRKDM4E
SCHEMBL11054518 0.81 MAPK1 (0.35) MAPK1GLAPOLBKDM4EKDM4C
SCHEMBL27295654 0.80 MAPK1 (0.36) MAPK1GLAALDH1A1TSHRKDM4E
SCHEMBL5809049 0.79 ALDH1A1 (0.47) MAPK1POLBALDH1A1TSHRKDM4E
SCHEMBL11054732 0.77 ALDH1A1 (0.40) MAPK1ALDH1A1TSHRHTTGPR84
SCHEMBL11053635 0.77 FFAR1 (0.39) MAPK1GLAPOLBKDM4CGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264624-A1 Methods for synthesizing imidazotriazinones LEXICON GENETICS INCORPORATED 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264624-A1 Methods for synthesizing imidazotriazinones PDE3A, PDE2A, PDE3B MAPK1 4703/4885GLA 1797/4885POLB 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.